https://ipharmag.com/article/osteoporosis-drug-development-reinvigorated-interest iPharmag en 2026-09-23T16:00:57+00:00 After Years of Neglect, Osteoporosis Drugs Are Suddenly Hot Again https://ipharmag.com/article/europe-biotech-decline-pharma-chairs-alarm iPharmag en 2026-09-23T16:00:57+00:00 Nine Pharma Chairs Warn Europe Is Losing the Biotech Race https://ipharmag.com/article/boomray-novartis-900m-radioligand-therapy-deal iPharmag en 2026-09-23T16:00:57+00:00 Novartis Pays Up to $900M for a Chinese Biotech’s Radioactive Cancer Drug https://ipharmag.com/article/boehringer-envisagenics-1-billion-rna-splicing-cancer-ai iPharmag en 2026-09-23T16:00:57+00:00 Boehringer Bets Over $1B on AI That Reads a Hidden Layer of Cancer Biology https://ipharmag.com/article/basecamp-research-140m-ai-designed-drugs-eden iPharmag en 2026-09-23T16:00:57+00:00 Anthropic- and Nvidia-Backed Startup Raises $140M to Let AI Design Living Medicines https://ipharmag.com/article/stopping-ozempic-glp1-cardiovascular-risk iPharmag en 2026-09-23T04:06:41+00:00 Stopping Ozempic-Type Drugs May Undo Their Heart Benefits, a Large Study Finds https://ipharmag.com/article/long-covid-dopamine-neurons-brain-fog-pet iPharmag en 2026-09-23T04:06:41+00:00 Brain Scans Point to a Physical Cause of Long-COVID Brain Fog: Lost Dopamine Neurons https://ipharmag.com/article/celldex-barzolvolimab-urticaria-anaphylaxis-safety iPharmag en 2026-09-23T04:06:41+00:00 Strong Results, Shaky Stock: A Hives Drug’s Safety Signal Rattles Investors https://ipharmag.com/article/amgen-dazodalibep-sjogrens-cd40l-phase3 iPharmag en 2026-09-23T04:06:41+00:00 Amgen Drug Hits Its Goals in Sjögren’s Disease, a Common Autoimmune Illness With No Approved Treatment https://ipharmag.com/article/aacr-us-cancer-mortality-down-35-percent iPharmag en 2026-09-23T04:06:41+00:00 U.S. Cancer Deaths Have Fallen 35% Since 1991, Saving 4.8 Million Lives https://ipharmag.com/article/sars-cov-2-orf8-macrophages-lung-inflammation iPharmag en 2026-09-22T01:57:08+00:00 Scientists Find How a SARS-CoV-2 Protein Turns the Immune System Against the Lungs https://ipharmag.com/article/lilly-inluriyo-verzenio-esr1-breast-cancer-approval iPharmag en 2026-09-22T01:57:08+00:00 FDA Approves an All-Oral Combo That Doubles Progression-Free Time in a Breast Cancer Subtype https://ipharmag.com/article/fda-galleri-multicancer-test-staff-no-major-concerns iPharmag en 2026-09-22T01:57:08+00:00 FDA Reviewers Raise No Major Concerns Over a Blood Test That Screens for Many Cancers https://ipharmag.com/article/drc-ebola-vaccination-health-workers-ervebo-outbreak iPharmag en 2026-09-22T01:57:08+00:00 Congo Starts Vaccinating Health Workers as Its Worst-Ever Ebola Outbreak Grows https://ipharmag.com/article/beacon-laru-zova-gene-therapy-xlrp-blindness-phase3 iPharmag en 2026-09-22T01:57:08+00:00 A Gene Therapy for an Inherited Blindness Just Passed Its Pivotal Test